Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auckland Uniservices LtdfiledCriticalAuckland Uniservices Ltd
Priority to NZ330758ApriorityCriticalpatent/NZ330758A/en
Publication of NZ330758ApublicationCriticalpatent/NZ330758A/en
The specification describes the use of a peptide selected from the group: (a) the tripeptide gly-pro-glu (GPE); (b) the dipeptide gly-pro and (c) the dipeptide pro-glu in the manufacture of a medicament for preventing or inhibiting death of neural cells in a mammal and therefore to treat neurological disease or disorder.
NZ330758A1993-12-231994-12-20Treatment of neural damage using GPE (the tripeptide gly-pro-glu)
NZ330758A
(en)
Use of flupirtin for producing pharmaceutical compositions suitable for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system